Dharti Proteins gets BSE nod to list 5 lakh shares
Dharti Proteins Ltd received BSE approval to list 5,00,000 equity shares of Rs. 10 each pursuant to an NCLT-approved resolution plan. The allotment includes shares for capital reduction, promoters, and secured creditors. The company is now finalizing depository procedures to commence trading.

*this image is generated using AI for illustrative purposes only.
Dharti Proteins Ltd has secured listing approval from BSE Limited for 5,00,000 equity shares of Rs. 10 each, following a resolution plan sanctioned by the National Company Law Tribunal (NCLT), Ahmedabad Bench. The approval, conveyed via letter DCS/AMAL/NB/IBC/52/2026-27 dated June 16, 2026, paves the way for the shares to be traded on the exchange. The company is currently executing corporate actions with NSDL and CDSL and will shortly apply for trading permission.
The share allotment was executed pursuant to the NCLT order dated November 18, 2025. The distribution includes 25,000 equity shares allotted due to a reduction of capital. The remaining 4,75,000 equity shares were allotted on a preferential basis, with 4,25,000 shares going to the Successful Resolution Applicant (SRA), identified as the Promoter or Promoter Group, and 50,000 shares allocated to a Secured Financial Creditor.
Allotment Breakdown
The following table details the distribution of the 5,00,000 equity shares approved for listing:
| Category | Number of Shares | Distinctive Numbers |
|---|---|---|
| Reduction of Capital | 25,000 | 1 – 25,000 |
| Successful Resolution Applicant (Promoter/Promoter Group) | 4,25,000 | 25,001 – 4,50,000 |
| Secured Financial Creditor | 50,000 | 4,50,001 – 5,00,000 |
| Total | 5,00,000 |
To facilitate trading, Dharti Proteins must submit several documents to the exchange, including ISIN activation letters, an auditor's certificate for book value determination, and confirmation letters from depositories regarding the credit of shares. Additionally, the company is required to provide pre- and post-arrangement shareholding patterns and lock-in confirmations as per SEBI (ICDR) Regulations, 2018.
The intimation was submitted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dharti Proteins Limited, formerly known as Devika Proteins Limited, is headquartered in Ahmedabad, Gujarat.
What is the expected timeline for the commencement of trading after the final submission of documents to the exchange?
How will the significant promoter shareholding of 85% impact the free float and liquidity of the stock once listed?
What strategic changes does the Promoter Group plan to implement following the successful resolution under the IBC process?































